Skip to main content

Table 2 Complications and outcomes of 86 patients hospitalized with RSV infection, 2012/13 winter season

From: Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study

Complication/outcome Number (%)
Lower respiratory tract complications1 45 (52%)
Cardiovascular complications2 19 (22%)
Pneumonia3 34 (40%)
  Confirmed radiologically 26 (30%)
  Unifocal infiltrate 18 (21%)
  Multifocal infiltrates 8 (9%)
  Lobar consolidation 11 (13%)
Co-pathogen identified4 11 (13%)
  Viral5 2 (2%)
  Bacterial6 9 (11%)
Need for intensive care 13 (15%)
Need for invasive mechanical ventilation 8 (9%)
In hospital mortality 5 (6%)
Median time to death (range) 6 days (2–52 days)
Median hospital length of stay (range) 6 days (1–140 days)
  1. 1Lower respiratory tract complications included exacerbation of COPD (n = 11) or asthma (n = 5), or pneumonia (n = 34).
  2. 2Cardiovascular complications included new arrhythmia (n = 7), CHF exacerbation (N = 12), myocardial infarction (n = 1), and stroke (n = 2).
  3. 3Pneumonia as diagnosed by treating physicians.
  4. 4Co-pathogen identified in nasopharyngeal swab, sputum or bronchoscopy specimen culture within 5 days of admission. No patients had concomitant bacteremia.
  5. 5Viral co-pathogens included influenza A (n = 1), and both influenza B and CMV in another patient.
  6. 6Bacterial co-pathogens included Haemophilus influenzae (n = 3), methicillin-sensitive Staphylococcus aureus (n = 1), Streptococcus pyogenes (n = 1), Streptococcus pneumoniae (n = 2), methicillin-resistant Staphylococcus aureus (n = 1), and Pseudomonas aeruginosa (n = 1).